Optogenetics uses light-sensitive proteins to change the activity of selected cells. A protein from a green alga helps explain how this research method begins.
The YouTube player loads only when you press Play. Playing connects to YouTube, which may use cookies and storage. See Privacy.
The alga that responds to light
Chlamydomonas is a single-celled green alga that can live in fresh water. It can swim toward light and has a small orange eyespot. This is a light-response system, rather than an eye like a human eye.
The opening blue flash acts on a cell that contains a special protein. It does not mean ordinary light controls every unmodified brain cell.
A sensor and a gate in one protein
Peter Hegemann proposes that the alga uses a protein that both detects light and controls ion movement. Georg Nagel and collaborators test genes for these proteins in other cells.
Channelrhodopsin-2 provides a light-sensitive route through the cell membrane. Blue light produces a response in less than a millisecond in the cited experiment. A millisecond is one thousandth of a second.
An ion is a charged particle. The channel allows positive ions to cross the membrane, changing the electrical difference between the cell's interior and exterior.
Why ion movement can make a nerve cell fire
A resting nerve cell has a relatively negative interior. Enough inward positive charge can move its voltage toward a threshold. Crossing that threshold can generate an action potential, which is a brief electrical signal.
The animation's moving dots show ions. The light-sensitive protein controls their path. The cell's existing electrical machinery then produces the signal.
The experiment in nerve cells
In 2005, Karl Deisseroth's team introduces the gene into rat nerve cells in a dish. The cells produce the protein in their membranes. Blue-light pulses then control their signals with millisecond timing.
Both parts of the method matter. The gene determines which cells have the light-sensitive tool. The light determines when that tool acts.
The prize and the research method
Karl Deisseroth, Peter Hegemann, and Georg Nagel share the medicine prize announced on October 5, 2026. Their work connects light-sensitive microbial proteins with a method for studying selected nerve cells.
Researchers can target particular cell populations and observe what changes during stimulation. This helps distinguish a causal contribution from a simple correlation. An active cell does not necessarily cause the behaviour that occurs beside its activity.
Mouse studies examine thirst, waking, and fear-associated memory. In a memory experiment, light reactivates cells active during an earlier fear-learning experience. The mice then show more freezing in another setting.
That result concerns a selected cell group and a measured response. It does not mean researchers read every part of a memory. The longer article explains these experiments in more detail.
One patient's partial visual recovery
A 2021 study reports one blind patient's partial recovery of visual function. The treatment makes surviving retinal nerve cells produce a light-sensitive protein. Special goggles project suitable light patterns onto those cells.
With the goggles, the patient can locate and count some objects on a table. Without them, he cannot detect the objects in the reported tests. The result depends on both the treatment and the goggles.
This is an early case with limited vision, rather than a cure for blindness. It does not establish that every blind person can benefit from the same treatment.
What this means
The alga's light-response machinery becomes a tool for testing cells. The final image connects that basic discovery with research and a carefully limited clinical example.
FAQ
Does the light work without a gene change?
The optogenetic example requires cells to produce the relevant light-sensitive protein.
Does the method only affect brain cells?
No. Researchers can study other suitable cells with appropriate tools and delivery methods.
Is the vision result normal sight?
No. The study reports partial function in one patient who uses special goggles.
Sources
- Boyden and colleagues: optical control of neurons
- Sahel and colleagues: partial visual recovery in one patient
- Stanford: the 2026 medicine Nobel Prize
- Adamantidis and colleagues: waking in mice
- Oka and colleagues: drinking behaviour in mice
- Liu and colleagues: fear-memory recall in mice
- Nobel Assembly: optogenetics discovery account
- Nagel and colleagues: channelrhodopsin-2
- Zhang and colleagues: optical inhibition
- Aravanis and colleagues: optical fibres and neural control
- Hsueh and colleagues: heart rate and behaviour in mice
- Buchanan and colleagues: sugar sensing in mice
- Sorbonne University: vision study methods and limits